Net Loss of Remedium Lifecare reported to Rs 53.72 crore in the quarter ended March 2024 as against net loss of Rs 4.78 crore during the previous quarter ended March 2023. Sales rose 1763.58% to Rs 1408.49 crore in the quarter ended March 2024 as against Rs 75.58 crore during the previous quarter ended March 2023.For the full year,net profit rose 502.76% to Rs 32.73 crore in the year ended March 2024 as against Rs 5.43 crore during the previous year ended March 2023. Sales rose 692.74% to Rs 4041.71 crore in the year ended March 2024 as against Rs 509.84 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales1408.4975.58 1764 4041.71509.84 693 OPM %-2.49-3.84 -0.821.47 - PBDT-35.99-2.80 -1185 50.517.55 569 PBT-36.00-2.81 -1181 50.457.40 582 NP-53.72-4.78 -1024 32.735.43 503 Powered by Capital Market - Live News

Remedium Lifecare has revised the meeting of the Board of Directors which was scheduled to be held on 10 May 2024. The meeting will now be held on 27 May 2024.Powered by Capital Market - Live News

Remedium Lifecare will hold a meeting of the Board of Directors of the Company on 10 May 2024.Powered by Capital Market - Live News

Remedium Lifecare has received an export order of Rs 169 crore from Pharmyka General Trading LLC, a pharmaceutical company situated in UAE. Powered by Capital Market - Live News

Remedium Lifecare will hold a meeting of the Board of Directors of the Company on 7 March 2024.Powered by Capital Market - Live News